Calidi Biotherapeutics, Inc. Debt Instrument, Interest Rate, Stated Percentage
Calidi Biotherapeutics, Inc. (CLDI) had Debt Instrument, Interest Rate, Stated Percentage of 24.00% as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2024-08-13
- 2024-06-30: Debt Instrument, Interest Rate, Stated Percentage 24.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2024-06-30 | 24.00% 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |